Literature DB >> 25573594

FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma.

Naomi Imayama1, Shin-Ichi Yamada, Souichi Yanamoto, Tomofumi Naruse, Yuki Matsushita, Hidenori Takahashi, Sachiko Seki, Shuichi Fujita, Tohru Ikeda, Masahiro Umeda.   

Abstract

Forkhead box protein C2 (FOXC2) is a gene encoding a transcription factor that controls the generation of mesodermal tissue including vascular and lymphatic tissues. FOXC2 has previously been associated with EMT and tumor angiogenesis in various cancers. Moreover, a relationship between the expression of FOXC2 and poor prognosis has been reported in various cancers. We herein examined the clinicopathological significance of FOXC2 in oral tongue squamous cell carcinoma (OTSCC) and attempted to clarify the function of FOXC2 in OTSCC cell lines in vitro. The overexpression of FOXC2 was more frequent in cancers with higher grades according to the pattern of invasion (grade 4 vs. 1-3; p < 0.05). A correlation was observed between the expression of FOXC2 and that of VEGF-A and -C (VEGF-A; p < 0.05, VEGF-C; p < 0.001). The high-FOXC2 expression group had a significantly poorer prognosis than that of the low-expression group (p < 0.001). Multivariate analysis indicated that the overexpression of FOXC2 may also be an independent prognostic factor, similar to N classification (N0 vs 1/2; p < 0.05), stage classification (stage I/II vs III/IV; p < 0.05), pattern of invasion (grade 1-3vs 4; p < 0.05), local recurrence (local recurrence (+) vs (-); p < 0.01), and the overexpression of FOXC2 (FOXC2 overexpression (-) vs.(+); p < 0.05). In the OTSCC cell line analysis, the expression of FOXC2 was also associated with proliferation and invasion potential. These results strongly suggest that the overexpression of FOXC2 may be a potent predictor of survival in OTSCC patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25573594     DOI: 10.1007/s12253-014-9891-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  36 in total

1.  Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma.

Authors:  Ming-Xing Ding; Xing-Qiu Lin; Xiao-Yan Fu; Ning Zhang; Ji-Cheng Li
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway.

Authors:  Tomofumi Naruse; Goro Kawasaki; Souichi Yanamoto; Akio Mizuno; Masahiro Umeda
Journal:  Anticancer Res       Date:  2011-12       Impact factor: 2.480

3.  Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.

Authors:  Agnes Bánkfalvi; Melanie Krassort; Igor B Buchwalow; Andras Végh; Endre Felszeghy; Jozsef Piffkó
Journal:  J Pathol       Date:  2002-11       Impact factor: 7.996

4.  p120-catenin is transcriptionally downregulated by FOXC2 in non-small cell lung cancer cells.

Authors:  Fariborz Mortazavi; Jiabin An; Steven Dubinett; Matthew Rettig
Journal:  Mol Cancer Res       Date:  2010-05-11       Impact factor: 5.852

5.  Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection.

Authors:  Wei Jiang; Xu-Guang Pang; Qun Wang; Ya-Xing Shen; Xiao-Ke Chen; Jun-Jie Xi
Journal:  Clin Lung Cancer       Date:  2011-12-16       Impact factor: 4.785

6.  The clinical significance of mesenchyme forkhead 1 (FoxC2) in gastric carcinoma.

Authors:  Jin-Liang Zhu; Yong-Xi Song; Zhen-Ning Wang; Peng Gao; Mei-Xian Wang; Yu-Lan Dong; Cheng-Zhong Xing; Hui-Mian Xu
Journal:  Histopathology       Date:  2013-04-24       Impact factor: 5.087

7.  Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.

Authors:  Raúl González-García; Luis Naval-Gías; Francisco J Rodríguez-Campo; Jesús Sastre-Pérez; Mario F Muñoz-Guerra; José L Gil-Díez Usandizaga
Journal:  J Oral Maxillofac Surg       Date:  2008-07       Impact factor: 1.895

8.  Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.

Authors:  Akira Watanabe; Hideki Suzuki; Takehiko Yokobori; Bolag Altan; Norio Kubo; Kenichiro Araki; Satoshi Wada; Yasushi Mochida; Shigeru Sasaki; Kenji Kashiwabara; Yasuo Hosouchi; Hiroyuki Kuwano
Journal:  Cancer Sci       Date:  2013-09-15       Impact factor: 6.716

Review 9.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

Review 10.  Vascular endothelial growth factor family of ligands and receptors: review.

Authors:  Zaher K Otrock; Jawad A Makarem; Ali I Shamseddine
Journal:  Blood Cells Mol Dis       Date:  2007-03-06       Impact factor: 3.039

View more
  7 in total

Review 1.  Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective.

Authors:  Kristian M Hargadon; Travis B Goodloe; Nathaniel D Lloyd
Journal:  Cancer Metastasis Rev       Date:  2022-06-14       Impact factor: 9.264

2.  Super-enhancer Acquisition Drives FOXC2 Expression in Middle Ear Cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Naotaro Akiyama; Hiromi Kojima
Journal:  J Assoc Res Otolaryngol       Date:  2021-04-16

Review 3.  Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Alhadi Almangush; Ilkka Heikkinen; Antti A Mäkitie; Ricardo D Coletta; Esa Läärä; Ilmo Leivo; Tuula Salo
Journal:  Br J Cancer       Date:  2017-07-27       Impact factor: 7.640

4.  Meta-analysis of the likelihood of FOXC2 expression in early- and late-stage tumors.

Authors:  Tsutomu Kume; Tarek Shackour
Journal:  Oncotarget       Date:  2018-09-07

5.  FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer.

Authors:  Astrid Børretzen; Karsten Gravdal; Svein A Haukaas; Christian Beisland; Lars A Akslen; Ole J Halvorsen
Journal:  J Pathol Clin Res       Date:  2019-10-01

6.  Meta-analysis of the prognostic significance of FOXC2 in various tumors.

Authors:  Bixia Xu; Yun Tian; Lin Liu
Journal:  J Int Med Res       Date:  2019-12-19       Impact factor: 1.671

7.  FOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition.

Authors:  Mika Pietilä; Geraldine V Vijay; Rama Soundararajan; Xian Yu; William F Symmans; Nathalie Sphyris; Sendurai A Mani
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.